New siRNA drug ADX-626 tested in humans for first time
NCT ID NCT07081503
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study is testing a new drug called ADX-626 in 44 healthy adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo (saline). The study does not aim to treat any disease, but to gather important safety information for future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ADX-626 (siRNA drug)
What this could lead to
If successful, this early study could pave the way for future trials of ADX-626 in specific diseases.
What could go wrong
This is a very early Phase 1 study in healthy people, so it won't show if the drug treats any disease. Side effects are possible, and the drug may not work as hoped in later trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Richmond Pharmacology
RECRUITINGLondon, SE1 1YR, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact